α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma

Breast Cancer Research and Treatment

Volumn 144, Issue 1, 2014, Pages 59-69

  Ito, Masaoki ^a   Hagiyama, Man ^b   Mimae, Takahiro ^a   Inoue, Takao ^b   Kato, Takashi ^b   Yoneshige, Azusa ^b   Nakanishi, Jun ^c   Kondo, Tadashi ^d   Okada, Morihito ^a   Ito, Akihiko ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c NIDEK CO LTD   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Adaptor protein; Biomarker; Excimer laser ablation; Invasive ductal carcinoma; Lymphatic invasion

Indexed keywords

ACTIN BINDING PROTEIN; ADAPTOR PROTEIN; ALPHA PARVIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL INFILTRATION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EXCIMER LASER; FOCAL ADHESION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; PSEUDOPODIUM; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VERY ELDERLY; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, LOBULAR; CELL LINE, TUMOR; CELL MOVEMENT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MASS SPECTROMETRY; MICROFILAMENT PROTEINS; MIDDLE AGED; PROTEOMICS; PSEUDOPODIA; TUMOR MARKERS, BIOLOGICAL;

EID: 84896736242     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2859-0     Document Type: Article

References (26)

1. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO Classification of Tumors of the Breast. International Agency for Research on Cancer, Lyon, France
2. Wasif N, Maggard MA, Ko CY, Giuliano AE (2010) Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol 17(7):1862-1869. doi: 10.1245/s10434-010-0953-z
3. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869-10874. doi: 10.1073/pnas.191367098
4. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF et al (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216(2):141-150. doi: 10.1002/path.2407
5. Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K et al (2010) The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol 220(1):45-57. doi: 10.1002/path.2629
6. Lauffenburger DA, Horwitz AF (1996) Cell migration: a physically integrated molecular process. Cell 84(3):359-369
7. Bravo-Cordero JJ, Hodgson L, Condeelis J (2012) Directed cell invasion and migration during metastasis. Curr Opin Cell Biol 24(2):277-283. doi: 10.1016/j.ceb.2011.12.004
8. Ito A, Mimae T, Yamamoto YS, Hagiyama M, Nakanishi J, Ito M et al (2012) Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis. Lab Invest 92(9):1374-1385. doi: 10.1038/labinvest.2012.98
9. Sepulveda JL, Wu C (2006) The parvins. Cell Mol Life Sci 63(1):25-35
10. Nikolopoulos SN, Turner CE (2000) Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J Cell Biol 151(7):1435-1448
11. Olski TM, Noegel AA, Korenbaum E (2001) Parvin, a 42 kDa focal adhesion protein, related to the alpha-actinin superfamily. J Cell Sci 114(Pt 3):525-538
12. Nikolopoulos SN, Turner CE (2002) Molecular dissection of actopaxin-integrin-linked kinase-Paxillin interactions and their role in subcellular localization. J Biol Chem 277(2):1568-1575
13. Yun SP, Ryu JM, Han HJ (2011) Involvement of β1-integrin via PIP complex and FAK/paxillin in dexamethasone-induced human mesenchymal stem cells migration. J Cell Physiol 226(3):683-692. doi: 10.1002/jcp.22383
14. Kovalevich J, Tracy B, Langford D (2011) PINCH: More than just an adaptor protein in cellular response. J Cell Physiol 226(4):940-947. doi: 10.1002/jcp.22437
15. Devallière J, Chatelais M, Fitau J, Gérard N, Hulin P, Velazquez L et al (2012) LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration. FASEB J 26(6):2506-2592. doi: 10.1096/fj.11-193383
16. Clarke DM, Brown MC, LaLonde DP, Turner CE (2004) Phosphorylation of actopaxin regulates cell spreading and migration. J Cell Biol 166(6):901-912
17. Pignatelli J, LaLonde SE, LaLonde DP, Clarke D, Turner CE (2012) Actopaxin (α-parvin) phosphorylation is required for matrix degradation and cancer cell invasion. J Biol Chem 287(44):37309-37320. doi: 10.1074/jbc.M112.385229
18. Mimae T, Okada M, Hagiyama M, Miyata Y, Tsutani Y, Inoue T et al (2012) Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin Cancer Res 18(4):945-955. doi: 10.1158/1078-0432.CCR-11-1946
19. Thomas ZI, Gibson W, Sexton JZ, Aird KM, Ingram SM, Aldrich A et al (2011) Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration. Br J Cancer 104(10):1575-1586. doi: 10.1038/bjc.2011.133
20. Zhang G, Brewster A, Guan B, Fan Z, Brown PH, Xu XC (2011) Tumor-suppressor activity of RRIG1 in breast cancer. BMC Cancer 11:32. doi: 10.1186/1471-2407-11-32
21. Koma Y, Furuno T, Hagiyama M, Hamaguchi K, Nakanishi M, Masuda M et al (2008) Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions. Gastroenterology 134(5):1544-1554. doi: 10.1053/j.gastro.2008.01.081
22. Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell Inc., New York
23. Kurosumi M (2007) Immunohistochemical assessment of hormone receptor status using a new scoring system (J-score) in breast cancer. Breast Cancer 14(2):189-193
24. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118-145
25. Turner CE (2000) Paxillin and focal adhesion signalling. Nat Cell Biol 2(12):E231-E236
26. van Horssen R, Hollestelle A, Rens JA, Eggermont AM, Schutte M, Ten Hagen TL (2012) E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells. Breast Cancer Res Treat 136(2):365-377. doi: 10.1007/s10549-012-2261-8